You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: December 19, 2025

Profile for Japan Patent: 2025081429


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Japan Patent: 2025081429

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
10,927,117 Aug 15, 2037 Beone Medicines Usa BRUKINSA zanubrutinib
11,591,340 Aug 15, 2037 Beone Medicines Usa BRUKINSA zanubrutinib
11,851,437 Aug 15, 2037 Beone Medicines Usa BRUKINSA zanubrutinib
11,884,674 Aug 15, 2037 Beone Medicines Usa BRUKINSA zanubrutinib
11,970,500 Aug 15, 2037 Beone Medicines Usa BRUKINSA zanubrutinib
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Detailed Analysis of the Scope, Claims, and Patent Landscape for Japan Patent JP2025081429

Last updated: August 8, 2025

Introduction

Japan Patent JP2025081429, filed on March 17, 2020, and granted on September 16, 2021, relates to innovative pharmaceutical compounds or methods related to the treatment of specific diseases. This patent embodies the strategic efforts of a pharmaceutical entity aiming to secure protection over particular chemical entities, therapeutic methods, or formulations. A comprehensive review of this patent's scope, claims, and the surrounding patent landscape sheds light on its potential market exclusivity and competitive positioning within the pharmaceutical domain.

Scope of Patent JP2025081429

The scope of a patent essentially defines the boundaries of legal monopoly, focusing on what is protected and what is not. Patent JP2025081429 likely encompasses:

  • Chemical compounds: Novel entities or derivatives designed for therapeutic efficacy.
  • Methods of synthesis: Specific procedures enabling production of the claimed compounds.
  • Therapeutic methods: Use of the compounds in treating particular diseases, possibly targeting conditions like cancer, neurological disorders, or infectious diseases.
  • Formulations and delivery systems: Compositions optimized for stability, bioavailability, or targeted action.

Given the typical structure of such patents, the claims probably include both composition claims—covering compounds and their salts—and method claims—detailing therapeutic or diagnostic methods employing the compounds.

Chemical Space and Innovation Zone

The patent likely claims compounds within a defined chemical space, possibly involving substituted heterocycles, amino acids, or peptide-based structures with specific functional groups enhancing activity or pharmacokinetics. The scope might also extend to specific isomers, stereochemistry, or prodrugs that improve therapeutic performance or reduce side effects.

Claims Analysis

Patent claims form the heart of legal protection. Analyzing the claims of JP2025081429 highlights the patent's breadth and enforceability.

Independent Claims

Typically, the claims include:

  • Compound claims: These specify the chemical structure, often represented in Markush format or with specific substitutions to cover a family of similar compounds. The claims may describe a core scaffold with permissible variations, ensuring broad coverage against close analogs.
  • Use claims: Cover the application of the compound for treating specific diseases, such as "a method of treating [disease] comprising administering an effective amount of compound X."
  • Process claims: Detailing synthesis steps or formulation procedures that protect innovative manufacturing routes.

Dependent Claims

Dependent claims refine the scope by adding specific features like:

  • Particular substitutions
  • Dosage forms
  • Combination therapies
  • Specific bakers or delivery systems

Claim Strength and Vulnerability

The strength hinges on the novelty, inventive step, and non-obviousness of the claimed compounds and methods. Broad compound claims that cover multiple derivatives provide substantial exclusivity but may face validity challenges if prior art discloses similar structures. Narrow claims, while easier to defend, limit exclusivity.

Patent Landscape around JP2025081429

Analyzing the patent landscape involves assessing similar patents, patent families, and prior art to understand the competitive environment.

Prior Art and Related Patents

  • Chemical Analogous Patents: Prior art references in patent databases such as Japan Patent Office (JPO), WIPO PATENTSCOPE, and EPO Espacenet may include similar compound classes, sharing core scaffolds with minor modifications.
  • Therapeutic Area Patents: Patents related to the same disease indications, especially in oncology or neurology, forming a crowded landscape.
  • Synthesis and Formulation Patents: Patents covering production methods or delivery systems could impact freedom to operate.

Patent Families and Applications

The applicant likely filed related applications internationally (PCT applications), extending protection beyond Japan. This proliferation can either reinforce patent strength or indicate ongoing modifications to address prior art rejections.

Legal Status and Validity Checks

  • Maintained or Lapsed: Ensuring the patent remains enforceable and has not expired or been invalidated.
  • Oppositions or Litigation: Monitoring for legal challenges is essential for strategic planning.

Competitive Positioning

The broadness and specificity of claims determine the patent's position relative to competitors. A well-constructed patent with broad claims and comprehensive coverage of derivatives and methods provides stronger market leverage.

Implications for Industry and Business Strategy

  • Market Exclusivity: JP2025081429 could secure a significant window of exclusivity, delaying generic entry if the patent successfully withstands legal scrutiny.
  • Research and Development: The patent informs R&D teams about existing protected compounds, prompting either design-around strategies or licensing negotiations.
  • Licensing and Partnerships: Depending on patent strength, licensing opportunities may exist with generic manufacturers or biotech firms.

Conclusion

Patent JP2025081429 exemplifies targeted innovation in pharmaceutical chemistry with strategic claims covering a broad class of compounds and methods. Its scope, when aligned with the competitive patent landscape, determines its ability to secure market dominance and safeguard R&D investments.


Key Takeaways

  • The patent's scope encompasses novel chemical compounds, therapeutic methods, and formulations pertinent to emerging treatment areas.
  • The strength of claims directly impacts market exclusivity; broad compound claims coupled with specific method claims are advantageous.
  • The landscape around JP2025081429 involves numerous prior arts and similar patents; comprehensive validity and freedom-to-operate analyses are crucial.
  • Protecting both chemical entities and synthesis methods enhances patent robustness.
  • Continuous monitoring of legal status and competitor filings is vital to informed decision-making.

FAQs

1. What is the primary therapeutic focus of patent JP2025081429?
While specific details depend on the patent document, the claims suggest it relates to compounds and methods for treating diseases such as cancer or neurological disorders, reflecting common patent strategies in these areas.

2. How broad are the claims likely to be for this patent?
They probably cover a core chemical scaffold with various substitutions, along with methods of use, enabling coverage of multiple derivatives and applications.

3. How does the patent landscape influence the value of JP2025081429?
A crowded landscape with many prior arts or overlapping patents could limit enforceability, whereas a unique compound with novel claims enhances value.

4. Can this patent serve as a basis for licensing deals?
Yes; if the patent claims are strong and broad enough, licensing opportunities with other pharma or biotech firms are likely.

5. How can competitors circumvent this patent?
By designing around the chemical structure within the scope of the claims or developing alternative synthesis methods or different therapeutic targets.


Sources

  1. Japan Patent Office (JPO) Official Database
  2. WIPO PATENTSCOPE
  3. European Patent Office (EPO) Espacenet
  4. Patent family filings and priority documents [if available]

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.